CLB (Core Laboratories) Financial Strength: 6 (As of Jun. 2026) — 20% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CLB Core Laboratories Inc CLB
66 GF Score
Price $12.45
GF Value $17.05
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Core Laboratories Financial Strength?

Core Laboratories CLB +0.48% 66 Financial Strength is 6 as of Jun. 2026, which is 20% above its 10-year median of 5.00. GuruFocus rates CLB with a GF Score™ of 66/100 and a GF Value™ of $17.05 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Core Laboratories has the Financial Strength Rank of 6.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is rated on a scale of 1 to 10 and is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.
4. Other debt related ratios.

A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.

Core Laboratories's Interest Coverage for the quarter that ended in Jun. 2026 was 2.97. Core Laboratories's debt to revenue ratio for the quarter that ended in Jun. 2026 was 0.33. As of today, Core Laboratories's Altman Z-Score is 2.92.


Core Laboratories  (NYSE:CLB) Financial Strength Explanation

The rank is rated on a scale of 1 to 10. A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.

Core Laboratories has the Financial Strength Rank of 6.


Core Laboratories Financial Strength Related Terms


CLB vs EROK, OIS, NGS: Financial Strength Comparison

For the Oil & Gas Equipment & Services subindustry, Core Laboratories's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Core Laboratories Financial Strength vs Oil & Gas Industry

For the Oil & Gas industry and Energy sector, Core Laboratories's Financial Strength distribution charts can be found below:

* The bar in red indicates where Core Laboratories's Financial Strength falls into.


CLB
66GF Score
Core Laboratories Inc CLB
Financial Strength is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Core Laboratories Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

Core Laboratories's Interest Expense for the months ended in Jun. 2026 was $-2.8 Mil. Its Operating Income for the months ended in Jun. 2026 was $8.5 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was $153.2 Mil.

Core Laboratories's Interest Coverage for the quarter that ended in Jun. 2026 is

Interest Coverage=-1*Operating Income (Q: Jun. 2026 )/Interest Expense (Q: Jun. 2026 )
=-1*8.46/-2.846
=2.97

The higher the ratio, the stronger the company's financial strength is.

2. Debt to revenue ratio. The lower, the better.

Core Laboratories's Debt to Revenue Ratio for the quarter that ended in Jun. 2026 is

Debt to Revenue Ratio=Total Debt (Q: Jun. 2026 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(11.94 + 153.175) / 498.436
=0.33

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

Core Laboratories has a Z-score of 2.92, indicating it is in Grey Zones. This implies that Core Laboratories is in some kind of financial stress. If it is below 1.81, the company may faces bankrupcy risk.

Warning Sign:

Altman Z-score of 2.92 is in the grey area. This implies that the company is under some kind of financial stress. If it is below 1.8, the company may face bankruptcy risk.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Financial Strength →
What does a Financial Strength of 6 mean?
Core Laboratories (CLB) has a Financial Strength of 6 as of Jun. 2026. The financial strength rank measures the strength of a company's balance sheet based on revenue and debt. View historical data on Core Laboratories and its competitors. This is 20% above median its historical median of 5.00. Over the past decade, Core Laboratories' Financial Strength has ranged from 4.00 to 6.00.
Is Core Laboratories' Financial Strength too high?
Core Laboratories' current Financial Strength of 6 is 20% above median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 6.00. Overall, Core Laboratories has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Core Laboratories' Financial Strength compare to EROK and OIS?
Core Laboratories' Financial Strength of 6 can be compared against companies in the Oil & Gas industry. Historically, Core Laboratories' own Financial Strength has ranged from 4.00 to 6.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Financial Strength for an Oil & Gas company?
A good Financial Strength depends on the Oil & Gas industry context. However, Financial Strength should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Financial Strength mean?
A high Financial Strength can signal that a stock is expensive relative to its fundamentals. The financial strength rank measures the strength of a company's balance sheet based on revenue and debt. View historical data on Core Laboratories and its competitors. Core Laboratories's current Financial Strength is 6, which is 20% above median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Core Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Core Laboratories (CLB) is currently considered Modestly Undervalued. The stock's GF Value™ is $17.05, compared to a current price of $12.45 — trading 27% below its estimated fair value. The current Financial Strength is 6, which is 20% above median its 10-year median of 5.00. Core Laboratories' overall GF Score™ is 66/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Financial Strength calculated?
Financial Strength is calculated from a company's financial statements. For Core Laboratories (CLB), the current Financial Strength is 6 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Core Laboratories (CLB) Overvalued in 2026?

Based on GuruFocus' analysis, Core Laboratories stock appears to be undervalued. The current stock price of $12.45 is trading 27% below its estimated GF Value™ of $17.05. GuruFocus considers Core Laboratories to be Modestly Undervalued.

Key valuation signals for CLB:

  • Financial Strength: 6 (20% above median its 10-year median of 5.00)
  • GF Value™: $17.05 vs. price of $12.45 (27% below fair value)
  • GF Score™: 66/100 with 2 warning signs

No single metric tells the full story. See the CLB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Core Laboratories Business Description

Industry EnergyOil & Gas
Other Exchanges HJ1:Germany
Address 6316 Windfern Road, Houston, TX, USA, 77040
Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.
66GF Score

Get the complete analysis for CLB

Financial Strength is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.45
Price
$17.05
GF Value